Our Pricing

Buy Single Weight Loss Injection Pen - UK Delivery

Published on: June 03, 2026

When you buy single weight loss injection pen UK options online, you gain access to MHRA-licensed GLP-1 treatments including Mounjaro, Wegovy, and Saxenda with transparent pricing from £135.00. At Cured Pharmacy, our UK-registered clinical team provides free online consultations in under 3 minutes, ensuring you receive the most appropriate treatment with discreet home delivery across the UK.

How GLP-1 Weight Loss Injection Pens Work

GLP-1 receptor agonists mimic naturally occurring incretin hormones that regulate appetite and blood glucose levels. These injectable medications slow gastric emptying, enhance satiety signals to the brain, and improve insulin secretion in response to meals [1]. The result is reduced hunger, smaller portion sizes, and sustainable weight reduction when combined with dietary modifications.

Mounjaro contains tirzepatide, the UK's first dual GIP/GLP-1 receptor agonist, which activates two complementary pathways rather than one [2]. In the SURPASS-1 trial, patients achieved average weight reductions of 15-22.5% depending on dose strength over 40 weeks, representing superior efficacy compared to single-pathway alternatives [2]. Wegovy and Saxenda both contain semaglutide and liraglutide respectively, well-established GLP-1 agonists with extensive clinical evidence supporting their use in weight management.

All three treatments require subcutaneous injection using pre-filled pens designed for home use. Each pen contains multiple doses, with injection frequency varying by medication: Mounjaro and Wegovy are administered once weekly, whilst Saxenda requires daily injections. Your UK prescriber will determine the appropriate starting dose and titration schedule based on your medical history and weight loss goals.

Comparing Single Pen Options: Mounjaro, Wegovy, and Saxenda

Mounjaro KwikPens deliver tirzepatide in graduated doses from 2.5mg to 15mg, with each pen containing four weekly doses. The dual-agonist mechanism produces robust weight reduction, with SURPASS-3 data showing average body weight reductions of 22.5% at the highest maintenance dose over 72 weeks [2][3]. Patients typically start at 2.5mg weekly, escalating every four weeks until reaching their optimal maintenance dose.

Wegovy pens contain semaglutide in doses ranging from 0.25mg to 2.4mg weekly. The STEP-1 trial demonstrated average weight loss of 14.9% over 68 weeks in adults with obesity, significantly outperforming placebo [4]. Wegovy follows a structured dose-escalation protocol to minimise gastrointestinal side effects, with most patients reaching the 2.4mg maintenance dose within 16-20 weeks.

Saxenda delivers liraglutide via daily injection, starting at 0.6mg and increasing to a maximum 3.0mg daily dose. Whilst daily administration requires more frequent injections, some patients prefer the steady-state drug levels this provides. Clinical trials showed average weight loss of 8% over 56 weeks when combined with reduced-calorie diet and increased physical activity [1].

Which Injection Pen Suits Your Lifestyle?

Your choice between these medications depends on several clinical and practical factors. Weekly injections with Mounjaro or Wegovy offer convenience and may improve adherence compared to daily Saxenda injections. However, patients with previous GLP-1 experience or specific tolerability concerns may benefit from the more gradual pharmacokinetic profile of daily liraglutide. Cost considerations also vary, with different price points reflecting medication type, dose strength, and treatment duration. Our UK prescribers assess your medical history, previous weight loss attempts, current medications, and personal preferences during your free online consultation to recommend the most suitable option.

Clinical Evidence Supporting Weight Loss Injection Pens

The SURPASS clinical trial programme established tirzepatide's efficacy across diverse patient populations. SURPASS-2 directly compared tirzepatide against semaglutide 1mg in adults with type 2 diabetes, demonstrating superior weight reduction with tirzepatide at all dose levels [3]. Participants receiving tirzepatide 15mg achieved average weight loss of 11.2kg compared to 5.7kg with semaglutide 1mg over 40 weeks, representing a statistically significant difference.

The STEP trials provided comprehensive evidence for semaglutide's role in weight management. STEP-1 enrolled 1,961 adults with obesity or overweight plus weight-related comorbidities, showing that 69% of semaglutide-treated participants achieved at least 10% weight loss compared to 12% receiving placebo [4]. Importantly, weight reduction was accompanied by improvements in cardiometabolic risk factors including waist circumference, blood pressure, and lipid profiles.

Long-term safety data spanning multiple years confirms that GLP-1 receptor agonists maintain acceptable tolerability profiles when prescribed appropriately. The most common side effects—nausea, diarrhoea, and constipation—typically occur during dose escalation and diminish with continued treatment [1][4]. Serious adverse events remain rare, though all GLP-1 medications carry specific contraindications that UK prescribers carefully screen for during clinical assessment.

Pricing and Value When You Buy Single Weight Loss Injection Pen UK

At Cured Pharmacy, transparent upfront pricing means you see exact costs before completing your clinical consultation. Our pricing structure reflects the specific medication, dose strength, and number of pens required for your treatment cycle. Unlike some providers who display starting prices that don't reflect realistic treatment costs, we ensure you understand the total investment required.

Single pen pricing varies by medication type and strength. Treatment costs should be considered alongside clinical efficacy, injection frequency, and your individual response. Many patients find that weekly injection pens offer better value over time compared to daily alternatives when factoring in convenience and adherence. Our UK clinical team can discuss cost-effective treatment pathways during your consultation, ensuring you receive appropriate therapy within your budget.

We guarantee the lowest prices in the UK for genuine, MHRA-licensed weight loss medications. All products dispensed by Cured Pharmacy come directly from UK-licensed wholesalers, ensuring complete medication authenticity and proper storage conditions. Superintendent Pharmacist Tarun Kumar (GPhC 2233073) personally oversees our quality assurance processes, and every prescription undergoes rigorous clinical review before dispensing.

What's Included in Your Treatment Package

Every weight loss injection pen order from Cured Pharmacy includes free UK-registered prescriber consultation, discreet packaging, and tracked delivery. You'll receive comprehensive patient information leaflets, injection technique guidance, and access to our clinical support team throughout your treatment. Needles appropriate for your prescribed pen are included where required, and we provide sharps disposal guidance to ensure safe medication administration at home.

The Online Consultation Process for Weight Loss Injections

Our streamlined online consultation takes under 3 minutes to complete and covers essential medical history, current medications, previous weight loss attempts, and relevant health conditions. UK-registered prescribers review every submission individually—there are no automated approvals. This clinical assessment ensures weight loss injections are safe and appropriate for your specific circumstances.

The consultation questionnaire asks about contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and diabetic retinopathy. You'll also provide information about current body weight, height, previous medication reactions, and any existing prescriptions. This comprehensive assessment allows our prescribers to identify potential drug interactions or clinical concerns before approving treatment.

Once approved, your prescription is electronically transmitted to our dispensary where GPhC-registered pharmacists prepare your medication for dispatch. Most orders are dispatched within 24-48 hours via tracked courier services, arriving in completely discreet packaging with no external indication of contents. If your clinical assessment identifies any concerns, our prescribers will contact you directly to discuss alternative options or request additional information from your GP.

Getting Started with Your Single Weight Loss Injection Pen

Beginning treatment with GLP-1 injection pens requires proper injection technique training and understanding of dose escalation protocols. Each medication follows specific titration schedules designed to minimise side effects whilst achieving therapeutic drug levels. Your patient information leaflet provides detailed injection instructions, but our clinical team remains available to answer technique questions throughout your treatment journey.

Most patients inject into subcutaneous tissue of the abdomen, thigh, or upper arm, rotating injection sites to prevent lipodystrophy. Pens should be stored in the refrigerator between 2-8°C until first use, then may be kept at room temperature for specified periods depending on the medication. Never freeze injection pens, and always inspect the solution for particulates or discolouration before injecting.

Optimal results occur when GLP-1 therapy combines with reduced-calorie nutrition and increased physical activity. Clinical trials demonstrating significant weight loss all included lifestyle intervention components alongside medication [2][4]. Your UK prescriber may recommend specific dietary approaches, and many patients benefit from keeping food diaries or working with registered dietitians to maximise treatment outcomes. Regular follow-up allows dose adjustments based on weight loss progress, tolerability, and individual response to therapy.

Monitoring Your Progress and Managing Side Effects

Common gastrointestinal effects including nausea, vomiting, and diarrhoea typically resolve within several weeks as your body adjusts to treatment. Eating smaller, more frequent meals and avoiding high-fat foods often reduces these symptoms. If side effects persist or become severe, contact our clinical team—dose adjustments or temporary treatment pauses may be appropriate. Serious symptoms like severe abdominal pain, persistent vomiting, or signs of pancreatitis require immediate medical attention and treatment discontinuation pending clinical evaluation.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., & Wilding, J. P. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Ludvik, B., Giorgino, F., Jódar, E., Frias, J. P., Fernández Landó, L., Brown, K., Bray, R., & Rodríguez, Á. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and physical activity levels.